APA (7th ed.) Citation

MS, S., AM, A., MSH, S., MH, A., S, T., YM, A. A., . . . R, E. (2025). Design and synthesis of sorafenib-inspired benzofuran hybrids as VEGFR-2 inhibitors: Antiproliferative evaluation, mechanistic insights, and docking studies in hepatocellular carcinoma. RSC medicinal chemistry. https://doi.org/10.1039/d5md00837a

Chicago Style (17th ed.) Citation

MS, Shehda, Almatary AM, Salem MSH, Aboutaleb MH, Takizawa S, Abdel Aziz YM, El-Sayed MAA, and Elrayess R. "Design and Synthesis of Sorafenib-inspired Benzofuran Hybrids as VEGFR-2 Inhibitors: Antiproliferative Evaluation, Mechanistic Insights, and Docking Studies in Hepatocellular Carcinoma." RSC Medicinal Chemistry 2025. https://doi.org/10.1039/d5md00837a.

MLA (9th ed.) Citation

MS, Shehda, et al. "Design and Synthesis of Sorafenib-inspired Benzofuran Hybrids as VEGFR-2 Inhibitors: Antiproliferative Evaluation, Mechanistic Insights, and Docking Studies in Hepatocellular Carcinoma." RSC Medicinal Chemistry, 2025, https://doi.org/10.1039/d5md00837a.